---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-010813"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T06:08:29.085554+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology announces $5M share repurchase program through April 2024

## Summary
- Board authorized up to $5M of common stock repurchases through April 30, 2024.
- Purchases will be made in open market transactions under Rule 10b-18.
- CEO Ronnie Morris cites confidence in strategic priorities and long-term prospects.
- CFO David Miller notes balance sheet strength and current valuation as buying opportunity.
- Program may be suspended, modified, or terminated at any time without notice.

## SEC filing metadata
- accession: 0001628280-23-010813
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828023010813/0001628280-23-010813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828023010813/csbr-20230405.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-010813
- JSON: https://secwatch.observer/filing/0001628280-23-010813.json
- Plain text: https://secwatch.observer/filing/0001628280-23-010813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.